Therapeutic combinations comprising (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
US7968565B2 · kind B2 · utility
33Cited by
9References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2005 |
| Grant date | Jun 28, 2011 |
| Priority date | — |
| Expiry date | Oct 19, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E70/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to SNS-595 and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.